Download PDF
Thromb Haemost 1994; 72(01): 160-161
DOI: 10.1055/s-0038-1648830
Letter to the Editor
Schattauer GmbH Stuttgart

Potency and In Vivo Recovery of High Purity Factor VIII Concentrates

Marianne Mikaelsson
1   Research and Development, University Hospital, Malmö, Sweden
,
Ulla Oswaldsson
1   Research and Development, University Hospital, Malmö, Sweden
,
Inga Marie Nilsson
2   Plasma Products, Kabi Pharmacia AB, and Department for Coagulation Disorders, University Hospital, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Received 24 June 1992

Accepted after revision 21 March 1994

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Barrowcliffe TW, Watton J, Harman A, Tubbs JE, Kemball-Cook G. Potency of high purity factor VIII concentrates. Lancet 1990; ii: 124
    PubMedGoogle Scholar
  • 2 Dawson NJ, Kemball-Cook G, Barrowcliffe TW. Assay discrepancies with highly purified factor VIII concentrates. Haemostasis 1989; 19: 131-137
    PubMedGoogle Scholar
  • 3 Nilsson IM, Bemtorp E. Clinical efficacy of clotting factor concentrates: survival, recovery and hemostatic capacity. In: Coagulation and Blood Transfusion Smit Sibinga CTh, Das PC, Mannucci PM. (eds) Dordrecht, The Netherlands: Kluwer Academic Publishers; 1991. pp 193-206
  • 4 Morfini M, Lee M, Messori A. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Thromb Haemost 1991; 66: 384-386
    Article in Thieme ConnectPubMedGoogle Scholar